Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Microsoft stock has weakened ahead of the company’s fiscal first-quarter report next Wednesday as investors are skittish on AI names. The post Microsoft Earnings Report To Focus On AI Momentum, Capex appeared first on Investor’s Business Daily.
IBD’s top-performing stock lists have just been updated. See which stocks got added – and which got cut. The post Nasdaq’s Stock Soars To New High, Leads 10 To Best Stock Lists While Its Index Plunges appeared first on Investor’s…
The S&P 500 and Nasdaq tumbled below 50-day lines as Meta led an AI stock rout. But the Warren Buffett market is thriving. The post Dow Jones Futures: Moderna Crashes, Meta Fuels AI Meltdown, But Warren Buffett Market Thriving appeared…
Chipmaker MaxLinear beat expectations for the third quarter and with its guidance for the fourth quarter. The post Chipmaker MaxLinear Delivers Beat-And-Raise Report appeared first on Investor’s Business Daily.
Chip stocks fell Thursday despite solid quarterly earnings reports from Texas Instruments and Lam Research. The post Chip Stocks Tumble Despite Solid Earnings Reports appeared first on Investor’s Business Daily.
Nasdaq Inc. Flashes Buy Signal As Nasdaq Composite Slides The post Nasdaq Inc., CSX Flash Buy Signals As Nasdaq, S&P 500 Slide appeared first on Investor’s Business Daily.
Quest Diagnostics did “good enough” against an “increasingly high bar,” an analyst said Thursday. But Quest stock fell moderately. The post Why Quest’s ‘Good Enough’ Third Quarter Wasn’t Actually Enough appeared first on Investor’s Business Daily.
Tesla CEO Elon Musk told investors to be patient when it came to progress on robotaxi expansion and Optimus development. The post Analysts Hike Tesla Price Targets; SpaceX Merger, AI ‘In Full Control’ appeared first on Investor’s Business Daily.
Roche stock was unmoved early Thursday after the drugmaker matched sales expectations despite light pharma sales. The post Roche, In A Buy Zone, Matches Revenue Forecasts Despite Light Pharma Sales appeared first on Investor’s Business Daily.
Argenx stock fell early Thursday despite beating sales expectations on a surprise testing requirement for its drug, Vyvgart. The post Argenx Slumps On Mixed Third Quarter, Surprise Vyvgart Testing Plans appeared first on Investor’s Business Daily.
